• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富马酸替诺福韦艾拉酚胺。

Tenofovir alafenamide fumarate.

机构信息

San Francisco, CA, USA.

Akero Therapeutics, South San Francisco, CA, USA.

出版信息

Antivir Ther. 2022 Apr;27(2):13596535211067600. doi: 10.1177/13596535211067600.

DOI:10.1177/13596535211067600
PMID:35499175
Abstract

Tenofovir alafenamide fumarate is a lipophilic prodrug of tenofovir which is preferentially metabolized in lymphatic tissue resulting in high concentrations of tenofovir (TFV) and its active diphosphate metabolite inside the cells that replicate HIV. Due to its selectivity for these tissues, lower total doses of TAF can be administered relative to tenofovir disoproxil fumarate (TDF) which results in improved bone and renal biomarkers. Tenofovir alafenamide fumarate has become the "backbone" of multiple combination products for the treatment of HIV, combined with emtricitabine for PreP and as a monotherapy for the treatment or HBV.

摘要

富马酸替诺福韦艾拉酚胺是替诺福韦的一种脂溶性前药,在淋巴组织中优先代谢,导致细胞内替诺福韦(TFV)及其活性二磷酸代谢物浓度升高,从而复制 HIV。由于其对这些组织的选择性,相对于富马酸替诺福韦二吡呋酯(TDF),可以给予较低的总替诺福韦艾拉酚胺剂量,从而改善骨和肾脏生物标志物。富马酸替诺福韦艾拉酚胺已成为多种用于治疗 HIV 的联合产品的“骨干”,与恩曲他滨联合用于 PrEP,也可作为治疗或 HBV 的单一疗法。

相似文献

1
Tenofovir alafenamide fumarate.富马酸替诺福韦艾拉酚胺。
Antivir Ther. 2022 Apr;27(2):13596535211067600. doi: 10.1177/13596535211067600.
2
Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF).替诺福韦艾拉酚胺(TAF)作为富马酸替诺福韦二吡呋酯(TDF)的后续药物。
Biochem Pharmacol. 2016 Nov 1;119:1-7. doi: 10.1016/j.bcp.2016.04.015. Epub 2016 Apr 29.
3
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial.在病毒学抑制的成人中,以恩曲他滨为骨架的固定剂量组合形式给予替诺福韦艾拉酚胺与替诺福韦酯治疗HIV-1感染的疗效和安全性:一项随机、双盲、活性对照3期试验。
Lancet HIV. 2016 Apr;3(4):e158-65. doi: 10.1016/S2352-3018(16)00024-2. Epub 2016 Mar 14.
4
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.恩曲他滨和丙酚替诺福韦艾拉酚胺与恩曲他滨和替诺福韦二吡呋酯用于 HIV-1 暴露前预防的长期安全性和有效性:一项随机、双盲、安慰剂对照、3 期临床试验的第 96 周结果。
Lancet HIV. 2021 Jul;8(7):e397-e407. doi: 10.1016/S2352-3018(21)00071-0.
5
Renal function in Japanese HIV-1-positive patients who switch to tenofovir alafenamide fumarate after long-term tenofovir disoproxil fumarate: a single-center observational study.长期服用富马酸替诺福韦二吡呋酯后换用富马酸替诺福韦艾拉酚胺的日本HIV-1阳性患者的肾功能:一项单中心观察性研究。
AIDS Res Ther. 2021 Dec 7;18(1):94. doi: 10.1186/s12981-021-00420-5.
6
Tenofovir-diphosphate in peripheral blood mononuclear cells during low, medium and high adherence to emtricitabine/ tenofovir alafenamide vs. emtricitabine/ tenofovir disoproxil fumarate.替诺福韦二吡呋酯在低、中、高依从性服用恩曲他滨/替诺福韦艾拉酚胺与恩曲他滨/替诺福韦富马酸酯时外周血单个核细胞中的浓度。
AIDS. 2021 Dec 1;35(15):2481-2487. doi: 10.1097/QAD.0000000000003062.
7
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study.从富马酸替诺福韦二吡呋酯转换为替诺福韦艾拉酚胺与利匹韦林和恩曲他滨固定剂量复方制剂用于病毒学抑制的 HIV-1 感染成人:一项随机、双盲、多中心、3b 期、非劣效性研究。
Lancet HIV. 2017 May;4(5):e195-e204. doi: 10.1016/S2352-3018(17)30031-0. Epub 2017 Mar 2.
8
Evaluating the combination of emtricitabine/ tenofovir alafenamide fumarate to reduce the risk of sexually acquired HIV-1-infection in at-risk adults.评估恩曲他滨/替诺福韦艾拉酚胺富马酸盐联合用药降低高危成年人经性感染 HIV-1 的风险。
Expert Opin Pharmacother. 2021 Jul;22(10):1245-1251. doi: 10.1080/14656566.2021.1902504. Epub 2021 Apr 1.
9
Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study.从依非韦伦、恩曲他滨和富马酸替诺福韦二吡呋酯转换为替诺福韦艾拉酚胺与利匹韦林和恩曲他滨联合复方制剂用于治疗 HIV-1 感染病毒抑制成人:一项随机、双盲、多中心、3b 期、非劣效性研究。
Lancet HIV. 2017 May;4(5):e205-e213. doi: 10.1016/S2352-3018(17)30032-2. Epub 2017 Mar 2.
10
Why Are Patients Switching from Tenofovir Disoproxil Fumarate/Emtricitabine (Truvada) to Tenofovir Alafenamide/Emtricitabine (Descovy) for Pre-Exposure Prophylaxis?为什么患者会将替诺福韦二吡呋酯/恩曲他滨(Truvada)转换为替诺福韦艾拉酚胺/恩曲他滨(Descovy)用于暴露前预防?
AIDS Patient Care STDS. 2021 Aug;35(8):327-334. doi: 10.1089/apc.2021.0033.

引用本文的文献

1
Overcoming Challenges in Small-Molecule Drug Bioavailability: A Review of Key Factors and Approaches.克服小分子药物生物利用度的挑战:关键因素与方法综述
Int J Mol Sci. 2024 Dec 6;25(23):13121. doi: 10.3390/ijms252313121.
2
The landscape of small-molecule prodrugs.小分子前药的领域。
Nat Rev Drug Discov. 2024 May;23(5):365-380. doi: 10.1038/s41573-024-00914-7. Epub 2024 Apr 2.
3
Weekly Oral Tenofovir Alafenamide Protects Macaques from Vaginal and Rectal Simian HIV Infection.每周口服替诺福韦艾拉酚胺可保护猕猴免受阴道和直肠猿猴免疫缺陷病毒感染。
Pharmaceutics. 2024 Mar 11;16(3):384. doi: 10.3390/pharmaceutics16030384.
4
Nucleos(t)ide analogs for hepatitis B virus infection differentially regulate the growth factor signaling in hepatocytes.核苷(酸)类似物治疗乙型肝炎病毒感染时可差异化调节肝细胞内生长因子信号通路。
Hepatol Commun. 2024 Jan 5;8(1). doi: 10.1097/HC9.0000000000000351. eCollection 2024 Jan 1.
5
Profiling of Peripheral TRBV and CD4+CD25+ Treg in CHB Patients with HBeAg SC during TDF Treatment.在 TDF 治疗期间,HBeAg 阴性慢性乙型肝炎患者外周血 TRBV 和 CD4+CD25+Treg 分析。
J Immunol Res. 2023 Jan 10;2023:1914036. doi: 10.1155/2023/1914036. eCollection 2023.